At the news
? NEUTRALIMPACT 2/10 DEFA14A filed Apr 24, 2026 at 16:14 ET
Evolent Health, Inc. (EVH) has filed a definitive proxy statement (DEFA14A) for its 2026 Annual Meeting, scheduled for June 4, 2026. The filing outlines four proposals for shareholder vote: election of 10 directors, ratification of Deloitte & Touche LLP as independent auditors, approval of executive compensation, and an amendment to the 2015 Omnibus Incentive Compensation Plan. The filing is routine and does not contain any material financial disclosures or significant corporate actions.
- Filing is a definitive proxy statement (DEFA14A) for Evolent Health's 2026 Annual Meeting
- Meeting date is June 4, 2026, with voting deadline of June 3, 2026
- Four proposals to be voted on: 1) Election of 10 directors, 2) Ratification of Deloitte & Touche LLP as independent auditors, 3) Approval of executive compensation, 4) Amendment to 2015 Omnibus Incentive Compensation Plan
- No material financial information, guidance, or significant corporate actions disclosed
Before · The news · First close · A day later · A week later
Replay the market's reaction
Step through every 5 minutes around the news, then see how it compares with similar events.
Subscribe for Full Access